The insulin-like growth factor-1 receptor (IGF-1R) is a transmembrane receptor with tyrosine kinase activity. The receptor plays a critical role in cancer. Using monoclonal antibodies (MAbs) against the IGF-1R, typically blocks ligand binding and enhances down-regulation of the cell-surface IGF-1R. Some MAbs such as cixutumumab are under clinical trial investigation. Targeting multiple distinct...

Persistent hyperglycemia resulting from diabetes mellitus causes microvascular lesions and long-term diabetic complications, such as nephropathy. The aim of the study was to analyze levels insulin-like growth factors (IGFs), their carrier proteins (IGFBP), markers kidney tissue damage (IL-18, L-FABP, cystatin C, NGAL, KIM-1) in male rats with mellitus, tumor growth, combination. Materials metho...

Background: Liver cirrhosis is one of the most significant causes death in many regions worldwide. This study aimed to assess correlation hemostatic and endocrine parameters with Child-Turcotte-Pugh (CTP) scoring patients non-alcoholic liver cirrhosis. Materials Methods: included 59 monitored for a gastroenterology clinic from January 2018 February 2019. The subjects were grouped according CTP ...

Introduction  Insulin-like growth factor I (IGF-I) which is produced in abundance in the normal adult liver, is deeply involved in hepatocyte survival, growth, and differentiation during liver development. IGF-I plays the roles via the receptor (IGF-IR) signaling pathway. IGF-IR unlike IGF-I is expressed strongly in the developing liver, but much more weakly in adults. Objective:  We hypothesi...

Severe cardiovascular diseases, such as myocardial infarction or heart failure, can alter thyroid hormone (TH) secretion and peripheral conversion, leading to low triiodothyronine (T3) syndrome. Accumulating evidence suggests that TH has protective properties against diseases treatment with effectively reduce damage after (MI). Our aim is investigate the effect of T3 pretreatment on cardiac fun...